Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis
Background/Aims: Treatment of refractory ulcerative colitis (UC) is a clinical challenge, and after biological therapy, monitoring clinical and endoscopic responses is fundamental. We aimed to investigate and compare the predictive power of different noninvasive parameters for clinical remission and...
Main Authors: | Elham A Hassan, Haidi K Ramadan, Ali A Ismael, Khaled F Mohamed, Madiha M El-Attar, Ihab Alhelali |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | The Saudi Journal of Gastroenterology |
Subjects: | |
Online Access: | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2017;volume=23;issue=4;spage=238;epage=245;aulast=Hassan |
Similar Items
-
Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation
by: Fernando Magro, et al.
Published: (2017-07-01) -
Colitis in spondyloarthritis
by: Muhammed Hafis, et al.
Published: (2020-01-01) -
Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis
by: Fang Chen, et al.
Published: (2021-08-01) -
The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis
by: Edyta Szymańska, et al.
Published: (2020-12-01) -
Role of Fecal Calprotectin as a Noninvasive Indicator for Ulcerative Colitis Disease Activity
by: Nakov Radislav V., et al.
Published: (2019-06-01)